CAFC Split on Abbott-Sandoz Litigation;A Patent on a Racemate Does Not Preclude One on an Enantiomer;CAFC Upholds Attorney,Expert Witness Fees;eBioscience Says It Is Not Infringing Invitrogen Patents;One Boniva Patent Found Invalid
Available accessResearch articleFirst published online February, 2009
CAFC Split on Abbott-Sandoz Litigation;A Patent on a Racemate Does Not Preclude One on an Enantiomer;CAFC Upholds Attorney,Expert Witness Fees;eBioscience Says It Is Not Infringing Invitrogen Patents;One Boniva Patent Found Invalid